Needle Free Drug Delivery Devices Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_00129579
- Format: Electronic (PDF)
- Publish Type: Publish
- Number of Pages: 250
Market Snapshot
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.6 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
The Needle-Free Drug Delivery Devices Market size is estimated to grow at a CAGR of 6.78% between 2022 and 2032. The market size is forecast to increase by USD 8,543.21 million. The growth of the market depends on several factors, including the rising prevalence of chronic diseases, increasing demand for self-administration of drugs, and technological advancements in drug delivery systems. Needle-free drug delivery devices refer to medical devices that enable the administration of medications without the use of traditional needles. These devices utilize various technologies such as jet injectors, transdermal patches, and inhalers to deliver drugs through the skin or mucosal membranes, providing a painless and convenient alternative to needle-based injections.
Needle-Free Drug Delivery Devices Market Overview
Drivers
One of the key factors driving the needle-free drug delivery devices market growth is the rising prevalence of chronic diseases. Chronic diseases such as diabetes, cardiovascular diseases, and autoimmune disorders require frequent administration of medications. Needle-free drug delivery devices offer a less invasive and more convenient method of drug administration, improving patient compliance and reducing the fear and discomfort associated with needle injections. As the global burden of chronic diseases continues to increase, the demand for needle-free drug delivery devices is expected to rise significantly.
Moreover, the increasing demand for self-administration of drugs is another driver of market growth. With the growing emphasis on patient-centered care and the need for home healthcare solutions, there is a rising trend of self-administration of medications. Needle-free drug delivery devices enable patients to administer medications themselves, eliminating the need for healthcare professionals and reducing healthcare costs. This convenience and autonomy provided by needle-free drug delivery devices are expected to fuel market growth during the forecast period.
Trends
A key trend shaping the needle-free drug delivery devices market is the technological advancements in drug delivery systems. Manufacturers are continuously investing in research and development to develop innovative and efficient drug delivery devices. For example, the development of microneedle patches that painlessly penetrate the skin and deliver drugs in a controlled manner has gained significant attention. Similarly, the use of inhalers for needle-free drug delivery is becoming increasingly popular, especially for respiratory medications. These technological advancements not only improve patient experience but also enhance drug efficacy and safety, driving the adoption of needle-free drug delivery devices.
Additionally, the integration of digital technologies in needle-free drug delivery devices is another trend in the market. The use of connected devices and smart sensors allows for real-time monitoring of drug administration, dosage tracking, and reminders, enhancing medication adherence and patient outcomes. The integration of digital technologies also enables healthcare providers to remotely monitor patient health and adjust treatment plans accordingly. Such advancements in digital health solutions are expected to propel market growth during the forecast period.
Restraints:
One of the key challenges hindering the needle-free drug delivery devices market growth is the high cost of these devices. Needle-free drug delivery devices are often more expensive than traditional needle-based devices, primarily due to the advanced technologies and materials used in their manufacturing. This high cost can limit their adoption, especially in developing countries with limited healthcare budgets. Additionally, the lack of reimbursement policies for needle-free drug delivery devices further hampers market growth. The affordability and reimbursement issues need to be addressed to ensure wider accessibility and adoption of these devices.
Furthermore, the regulatory challenges associated with the approval and commercialization of needle-free drug delivery devices pose a restraint to market growth. These devices need to undergo rigorous testing and meet stringent regulatory requirements to ensure their safety and efficacy. The lengthy and complex regulatory processes can delay the market entry of new devices, limiting the growth potential of the market.
Needle-Free Drug Delivery Devices Market Segmentation By Application
The diabetes management segment is estimated to witness significant growth during the forecast period. Needle-free drug delivery devices offer a convenient and painless method of insulin administration for diabetic patients. These devices eliminate the need for multiple daily injections, reducing the discomfort and inconvenience associated with traditional insulin delivery methods. Needle-free devices such as jet injectors and transdermal patches provide a more patient-friendly approach to insulin therapy, improving treatment adherence and overall diabetes management. The increasing prevalence of diabetes worldwide and the growing demand for innovative insulin delivery solutions are expected to drive the growth of this segment, thereby contributing to the overall market growth during the forecast period.
Needle-Free Drug Delivery Devices Market Segmentation By Type
The jet injectors segment is expected to dominate the needle-free drug delivery devices market during the forecast period. Jet injectors use high-pressure streams of medication to penetrate the skin and deliver drugs into the underlying tissues. These devices offer rapid and efficient drug delivery, making them suitable for a wide range of therapeutic applications. Jet injectors are commonly used for vaccines, insulin, and other medications that require subcutaneous or intramuscular administration. The ease of use, precise dosage delivery, and minimal pain associated with jet injectors make them a preferred choice for both healthcare professionals and patients. The increasing adoption of jet injectors in various healthcare settings is expected to drive the growth of this segment.
Regional Overview
North America is estimated to contribute significantly to the growth of the global needle-free drug delivery devices market during the forecast period. The region has a well-established healthcare infrastructure, favorable reimbursement policies, and a high prevalence of chronic diseases. The increasing adoption of advanced drug delivery technologies and the presence of key market players in the region further contribute to market growth. Additionally, the growing demand for self-administration of medications and the emphasis on patient-centered care are driving the adoption of needle-free drug delivery devices in North America. The availability of advanced healthcare facilities and the presence of a large patient pool make North America a lucrative market for needle-free drug delivery devices.
In 2020, during the COVID-19 pandemic, the needle-free drug delivery devices market witnessed a temporary slowdown due to disruptions in the healthcare system and supply chain. However, with the gradual resumption of healthcare services and the increasing focus on vaccination campaigns, the market is expected to recover and witness significant growth in the coming years.
Needle-Free Drug Delivery Devices Market Customer Landscape
The needle-free drug delivery devices market industry report includes an analysis of the customer landscape, focusing on the adoption rates and preferences of different customer segments. It provides insights into the factors influencing customer purchasing decisions, such as product features, pricing, and brand reputation. The report also highlights the key drivers of customer loyalty and the strategies adopted by companies to attract and retain customers.
Who are the Major Needle-Free Drug Delivery Devices Market Companies?
Companies in the needle-free drug delivery devices market are implementing various strategies to gain a competitive edge and expand their market presence. These strategies include product launches, partnerships, collaborations, and acquisitions. Some of the major market players in the needle-free drug delivery devices market include:
- Johnson & Johnson (J&J): J&J is a multinational pharmaceutical and medical device company that offers needle-free drug delivery systems through its subsidiary, Janssen Pharmaceuticals. They have developed devices like the INJEXTM needle-free injection system.
- 3M Company: 3M offers a variety of healthcare products, including needle-free drug delivery systems like the 3M™ Press-On™ OptiSet™ Needle-Free Luer Access Device.
- Zogenix:Zogenix specializes in the development and commercialization of innovative central nervous system (CNS) therapies. They have needle-free delivery systems for certain medications.
- PharmaJet:PharmaJet is a leading developer of needle-free injection technology. They offer devices like the PharmaJet Stratis® Needle-Free Injection System for various vaccines and medications.
- Portal Instruments: Portal Instruments focuses on advanced needle-free drug delivery technologies and has developed the Portal Patch, a needle-free injector.
- Johnson & Johnson
- Medtronic plc
- Insulet Corporation
- Zogenix, Inc.
- 3M Company
- Antares Pharma, Inc.
- Inovio Pharmaceuticals, Inc.
- Pharmajet, Inc.
- Portal Instruments
- Valeritas Holdings, Inc.
These companies are focusing on developing innovative needle-free drug delivery devices, expanding their product portfolios, and strengthening their distribution networks to gain a competitive advantage in the market.
The needle-free drug delivery devices market report provides a comprehensive analysis of the competitive landscape, including detailed profiles of 15 market companies. It includes information on their product portfolios, financial performance, strategic initiatives, and recent developments. The report also analyzes the market share and market positioning of these companies to provide insights into their competitive strategies and market presence.
Segment Overview
The needle-free drug delivery devices market report provides a detailed analysis of the market segmentation based on application, type, and geography. The application segment includes diabetes management, vaccine delivery, pain management, and others. The type segment includes jet injectors, transdermal patches, inhalers, and others. The report provides revenue forecasts for each segment at the global, regional, and country levels, offering insights into the latest market trends and growth opportunities.
- Application Outlook (USD Million, 2019 - 2032)
- Diabetes Management
- Vaccine Delivery
- Pain Management
- Others
- Type Outlook (USD Million, 2019 - 2032)
- Jet Injectors
- Transdermal Patches
- Inhalers
- Others
- Geography Outlook (USD Million, 2019 - 2032)
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- South America
- Brazil
- Argentina
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
TABLE OF CONTENTS: GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET
Chapter 1. MARKET SYNOPSIS
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. EXECUTIVE SUMMARY
2.1. Summary Snapshot, 2016 – 2027
Chapter 3. INDICATIVE METRICS
3.1. Macro Indicators
Chapter 4. NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SEGMENTATION & IMPACT ANALYSIS
4.1. Needle-Free Drug Delivery Devices Segmentation Analysis
4.2. Industrial Outlook
4.3. Price Trend Analysis
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.5.1. Power Of Suppliers
4.5.2. Power Of Buyers
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
Chapter 5. NEEDLE-FREE DRUG DELIVERY DEVICES MARKET BY Device Type INSIGHTS & TRENDS
5.1. Segment 1 Dynamics & Market Share, 2019 & 2027
5.2. Inhalers
5.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
5.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
5.3. Jet Injectors
5.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
5.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
5.4. Novel Needle
5.4.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
5.4.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
5.5. Transdermal Patch
5.5.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
5.5.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
Chapter 6. NEEDLE-FREE DRUG DELIVERY DEVICES MARKET BY Application INSIGHTS & TRENDS
6.1. Segment 2 Dynamics & Market Share, 2019 & 2027
6.2. Insulin Delivery
6.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
6.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
6.3. Vaccination
6.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
6.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
6.4. Pain Management
6.4.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)
6.4.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)
Chapter 7. NEEDLE-FREE DRUG DELIVERY DEVICES MARKET REGIONAL OUTLOOK
7.1. Needle-Free Drug Delivery Devices Market Share By Region, 2019 & 2027
7.2. NORTH AMERICA
7.2.1. North America Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.2.2. North America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.2.3. North America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.2.4. North America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.2.5. U.S.
7.2.5.1. U.S. Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.2.5.2. U.S. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.2.5.3. U.S. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.2.5.4. U.S. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.2.6. CANADA
7.2.6.1. Canada Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.2.6.2. Canada Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.2.6.3. Canada Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.2.6.4. Canada Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.3. EUROPE
7.3.1. Europe Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.3.2. Europe Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.3.3. Europe Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.3.4. Europe Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.3.5. GERMANY
7.3.5.1. Germany Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.3.5.2. Germany Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.3.5.3. Germany Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.3.5.4. Germany Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.3.6. FRANCE
7.3.6.1. France Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.3.6.2. France Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.3.6.3. France Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.3.6.4. France Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.3.7. U.K.
7.3.7.1. U.K. Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.3.7.2. U.K. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.3.7.3. U.K. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.3.7.4. U.K. Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.4. ASIA-PACIFIC
7.4.1. Asia Pacific Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.4.2. Asia Pacific Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.4.3. Asia Pacific Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.4.4. Asia Pacific Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.4.5. CHINA
7.4.5.1. China Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.4.5.2. China Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.4.5.3. China Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.4.5.4. China Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.4.6. INDIA
7.4.6.1. India Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.4.6.2. India Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.4.6.3. India Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.4.6.4. India Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.4.7. JAPAN
7.4.7.1. Japan Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.4.7.2. Japan Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.4.7.3. Japan Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.4.7.4. Japan Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.4.8. AUSTRALIA
7.4.8.1. Australia Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.4.8.2. Australia Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.4.8.3. Australia Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.4.8.4. Australia Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.5. MIDDLE EAST AND AFRICA (MEA)
7.5.1. Mea Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.5.2. Mea Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.5.3. Mea Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.5.4. Mea Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
7.6. LATIN AMERICA
7.6.1. Latin America Needle-Free Drug Delivery Devices Market Estimates And Forecast, 2016 – 2027, (USD Million)
7.6.2. Latin America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)
7.6.3. Latin America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)
7.6.4. Latin America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Production Process, 2016 –2027, (USD Million)
7.6.5. Latin America Needle-Free Drug Delivery Devices Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)
Chapter 8. COMPETITIVE LANDSCAPE
8.1. Market Share By Manufacturers
8.2. Strategic Benchmarking
8.2.1. New Product Launches
8.2.2. Investment & Expansion
8.2.3. Acquisitions
8.2.4. Partnerships, Agreement, Mergers, Joint-Ventures
8.3. Vendor Landscape
8.3.1. North American Suppliers
8.3.2. European Suppliers
8.3.3. Asia-Pacific Suppliers
8.3.4. Rest Of The World Suppliers
Chapter 9. COMPANY PROFILES
9.1. Akra Dermojet
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Insights
9.1.4. Strategic Initiatives
9.2. Injex Pharma AG
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Insights
9.2.4. Strategic Initiatives
9.3. PharmaJet
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Insights
9.3.4. Strategic Initiatives
9.4. 3M Company
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Insights
9.4.4. Strategic Initiatives
9.5. PenJet
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Insights
9.5.4. Strategic Initiatives
9.6. Company 6
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Insights
9.6.4. Strategic Initiatives
9.7. Company 7
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Insights
9.7.4. Strategic Initiatives
9.8. Company 8
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Insights
9.8.4. Strategic Initiatives
9.9. Company 9
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Insights
9.9.4. Strategic Initiatives
9.10. Company 10
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Insights
9.10.4. Strategic Initiatives
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"